Premium
Effect of Glutamine‐Supplemented Parenteral Nutrition on Mortality in Critically Ill Patients
Author(s) -
Sacks Gordon S.
Publication year - 2011
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0884533610392923
Subject(s) - medicine , critically ill , parenteral nutrition , glutamine , intensive care medicine , critical illness , amino acid , biochemistry , chemistry
Glutamine is recognized as a critical amino acid involved in immunity, intestinal health, and nitrogen transport between organs. Prior to the pivotal study by Griffiths and colleagues in 1997, no clinical trials had demonstrated a positive effect from glutamine supplementation on improving long‐term survival in critically ill intensive care unit patients receiving parenteral nutrition. Subsequent investigations have confirmed these findings, but further data are needed to determine the optimal dose and timing of glutamine as well as the form of glutamine (ie, free vs dipeptide) that produces the most significant improvement in outcome parameters. (Nutr Clin Pract. 2011;26:44–47)